You just read:

Shionogi Announces Commercial Availability of CUVPOSA™ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions

News provided by

Shionogi Inc.

Apr 07, 2011, 08:00 ET